Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share
Get Alerts PBYI Hot Sheet
Join SI Premium – FREE
Puma Biotech (NYSE: PBYI) reported Q4 EPS of ($1.23), versus ($1.03) reported last year.
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Canaccord Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
- BTIG Assumes Essent Group (ESNT) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share